Breast Cancer Market Growth by Top Companies, Trends by Types and Application, Forecast to 2030
Breast cancer is defined as a type of cancer where a lump is
formed in the breast, and red patches appear on the skin when cells of breast
tissue become cancerous. Market Research Future (MRFR) has published and
released a research report about the global Breast
Cancer Market that anticipates great boost with 9.2% CAGR (Compound Annual
Growth Rate) for this market between 2022 and 2030. Observing the market structure,
this report evaluates the future growth potential of the market and analyzes
the approaches of the key players in the market. It also follows the
competitive developments such as joint ventures, new product developments,
mergers and acquisitions, research and developments (R & D) in the market.
The key factors that drive this market include the adoption
of an unhealthy lifestyle, exposure to harmful radiation, increasing female
geriatric population, increasing governmental initiatives, and increasing
number of females suffering from breast cancer. However, there are some factors
that can hamper the growth of this market. Such factors include adverse effects
associated with the therapy, high cost of the treatment, and long approval time
for the drugs.
Segmentation-
The global Breast cancer Market has been segmented on the
basis of end user, treatment, type, and lastly, region. Based on end users,
this market has been segmented
·
on the basis of hospital pharmacies,
private pharmacies, and others.
·
The treatment-based segmentation of this
market covers biologic therapy, chemotherapy, hormone therapy, surgery &
radiation therapy, and targeted therapy.
·
Chemotherapy has been further segmented
into alkylating agents, antimetabolites, anthracyclines, and taxanes. The
targeted therapy has been further segmented into monoclonal antibodies and
tyrosine kinase inhibitors.
·
By type-based segmentation, the market
has been segmented into invasive ductal carcinoma, invasive lobular carcinoma,
others.
Key Players
The key players in the global Breast cancer market include
Accord Healthcare,
Inc. (India), Actavis Inc. (USA), Apthera Inc (UK), Astellas (Japan), AstraZeneca (UK), Bayer AG (Germany),
BioNumerik Pharmaceuticals (USA), Bipar Sciences (USA), Bristol-Myers Squibb
Company (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche (Switzerland),
Genentech (USA), Gilead Sciences Inc. (USA), GlaxoSmithKline (UK), Hospira, Inc.
(USA), Novartis AG (Switzerland), Oncogenex (USA), Oncothyreon Inc (USA),
Pfizer (USA), Puma Biotechnology (USA), Sanofi S.A. (USA), Sun Pharmaceutical
Industries Ltd (India), and Teva Pharmaceutical Industries (Israel).
Regional Segmentation:
The regional segmentation of the global liquid
biopsy breast cancer market segments the market into regional markets
namely The Americas (North America & South America), Asia Pacific, Europe,
and the Middle East & Africa (MEA). The Americas dominate the global
market. Changing lifestyle and increasing prevalence of breast cancer in the
Americas has driven the growth of the market. In the Americas, North America is
a bigger market than South America because more advanced medical facilities
being available in North America and many key players in the market is based in
Canada and the United States of America (USA).
The second biggest market is in Europe. Due to the reasons
same as The Americas, Western Europe is a bigger market than Eastern Europe.
The most significant country-based markets in Western Europe are France,
Germany, Italy, Spain, and the United Kingdom (UK). Technological advancement,
increased life expectancy and increasing disposable income regarding healthcare
expenditure of people are driving the market growth in the Americas and
Europe.
According to the report, Asia Pacific is expected to emerge
as the fastest growing market during the forecast period. The most significant
country-specific markets in the Asia Pacific region are Australia, China,
Japan, and South Korea, followed by the rest of Asia Pacific. MEA region is a
small market. The market is low due to lack of awareness, lack of education,
lack of technological development, political instability, poor healthcare, and
healthcare not considered a priority by most governments. The most important
country-specific markets in this region are Kuwait, Oman, Saudi Arabia, Qatar,
and the United Arab Emirates (UAE).
Latest Industrial News
- Roberta
Lombardi, founder, and CEO of Infinite Beauty has designed a new bra to
make breast cancer patients feel normal. 11 SEP 2018
- Biotechnology
Company, Oncolytic Biotech, has announced a clinical collaboration with an
academic research group. This collaboration is dedicated to clinical and
translational research in breast cancer, SOLTI. 11 SEP 2018
Related Report-
https://tannda.net/read-blog/12281
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment